Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Merck
Boehringer Ingelheim
Dow
McKesson
Express Scripts
AstraZeneca

Last Updated: January 23, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Drotaverine

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What is the development status for investigational drug Drotaverine?

Drotaverine is an investigational drug.

There have been 6 clinical trials for Drotaverine. The most recent clinical trial was a Phase 3 trial, which was initiated on May 1st 2016.

The most common disease conditions in clinical trials are Asphyxia Neonatorum, Asphyxia, and Pancreatic Diseases. The leading clinical trial sponsors are eran ashwal, Ain Shams Maternity Hospital, and Ain Shams University.

There are one hundred and twenty-six US patents protecting this investigational drug and one international patent.

Recent Clinical Trials for Drotaverine
TitleSponsorPhase
Morphine Versus Ketorolac in Renal ColicLoredana GhineaPhase 4
The Impact of Papaverine on First Stage of Laboreran ashwalPhase 3
Drotaverine to Shorten the Length of LaborAin Shams Maternity HospitalPhase 2/Phase 3

See all Drotaverine clinical trials

Clinical Trial Summary for Drotaverine

Top disease conditions for Drotaverine
Top clinical trial sponsors for Drotaverine

See all Drotaverine clinical trials

US Patents for Drotaverine

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Drotaverine   Start Trial Tolerogenic synthetic nanocarriers for generating CD8+ regulatory T cells Selecta Biosciences, Inc. (Watertown, MA)   Start Trial
Drotaverine   Start Trial Method for providing polymeric synthetic nanocarriers for generating antigen-specific tolerance immune responses Selecta Biosciences, Inc. (Watertown, MA)   Start Trial
Drotaverine   Start Trial Methods and compositions for attenuating gene expression modulating anti-viral transfer vector immune responses Selecta Biosciences, Inc. (Watertown, MA)   Start Trial
Drotaverine   Start Trial Gas-filled microvesicles composition for contrast imaging BRACCO SUISSE S.A. (Manno, CH)   Start Trial
Drotaverine   Start Trial Immediate/delayed drug delivery UNIVERSITY OF STRATHCLYDE (Glasgow, GB)   Start Trial
Drotaverine   Start Trial Solid solution compositions and use in chronic inflammation Infirst Healthcare Limited (London, GB)   Start Trial
Drotaverine   Start Trial Solid solution compositions and use in chronic inflammation Infirst Healthcare Limited (London, GB)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Drotaverine

Drugname Country Document Number Estimated Expiration Related US Patent
Drotaverine Australia 2011279250 2030-07-12   Start Trial
Drotaverine Australia 2012249401 2030-07-12   Start Trial
Drotaverine Australia 2012249419 2030-07-12   Start Trial
Drotaverine Australia 2012249493 2030-07-12   Start Trial
Drotaverine Australia 2012249537 2030-07-12   Start Trial
Drotaverine Australia 2012249540 2030-07-12   Start Trial
Drotaverine Australia 2012249544 2030-07-12   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
McKesson
Medtronic
Dow
Baxter
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.